Clinical Trials Logo
  1. Home
  2. Venous Insufficiency of Leg
  3. NCT04758728

Adrenaline Reduces Ecchymoses and Hematomas and Improves Quality of Life After Classic Saphenous Vein Stripping — ARESQOLSAVES  

Venous Reflux Clinical Trial

Official title:
The Role of Adrenaline in the Reduction of Subcutaneous Ecchymoses and Hematomas and in the Improvement of the Quality of Life of Patients After Classic Great Saphenous Vein Stripping

Clinical Trial Summary

Aim of the present study is to investigate the efficiency of adrenaline (epinephrine) used locally in reducing and avoiding post-operative formation of subcutaneous ecchymoses and hematomas, in comparison with traditional practice of hemostasis, and to assess improvement in the quality of life of subjects undergoing classic great saphenous vein stripping, who received or did not receive adrenaline as a local hemostatic.

Clinical Trial Description

Introduction Quality of life of subjects undergoing classic great saphenous vein stripping is analogous of the gravity of subcutaneous ecchymoses and hematomas formation, as a result of surgical interventions during open surgery, when the great saphenous vein is being removed. Adrenaline (epinephrine) is a potent vasoconstrictor, whose local hemostatic ability has already been documented and applied in many medical specialties. Aim of the present study to investigate the efficiency of adrenaline (epinephrine) used locally in reducing and avoiding post-operative formation of subcutaneous ecchymoses and hematomas, in comparison with traditional practice of hemostasis, and to assess improvement in the quality of life of subjects undergoing classic great saphenous vein stripping, who received or did not receive adrenaline as a local hemostatic. Material-Methods 40 subjects diagnosed with chronic venous insufficiency (CVI) and/or varicose veins of the lower limbs of varied clinical gravity (CEAP classification II & III), admitted in the department of Vascular Surgery for open surgical management, i.e. great saphenous vein stripping +/- removal of varicosities, will be enrolled after signing an informed consent for their participation in the study. They will be then randomized into 3 separate groups: Group A - great saphenous vein stripping with local adrenaline use for hemostasis Group B - great saphenous vein stripping with local normal saline use for hemostasis Group C - great saphenous vein stripping with traditional hemostatic practice Study subjects will be followed-up after surgery, and in each group measurement of ecchymoses (small 2-5mm2 and large >5mm2) and hematomas (medium 0,2-1cm and large >1cm) will be performed by using ImageJ software after digital high-resolution photographing on 1st, 8th and 14th post-operative days. Quality of life of subjects will be assessed pre-operatively and 1 month post-operatively, by using SF-36 and CIVIQ-2 questionnaires for QoL in CVI. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04758728
Study type Interventional
Source Junior Doctors Network-Hellas
Contact
Status Completed
Phase N/A
Start date September 10, 2015
Completion date June 10, 2016
View Details
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05504070 - Venclose digiRF System Post Market Study N/A
Recruiting NCT05633277 - Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections N/A
Completed NCT02553720 - The ATLANTIS Trial N/A
Withdrawn NCT02936271 - Efficacy of Vasculera in Prevention on Post-op Pain and Edema Following Lower Extremity Venous Treatment in the Outpatient Setting N/A
Completed NCT02585726 - Lake Washington Vascular VenaSeal™ Post-Market Evaluation (WAVES) N/A
Active, not recruiting NCT04339075 - Registry to Investigate the Efficacy and Safety of VenaBlock VeIn SEaling System for VaRicose Veins in SingApore
Recruiting NCT04146168 - Lake Washington Vascular VenaSeal™ Post-Market Evaluation
Not yet recruiting NCT01901731 - Pelvic Embolisation to Reduce Recurrent Varicose Veins - Primary N/A
Completed NCT00509392 - ClosureFAST vs. Laser Ablation for the Treatment of GSV Disease: A Multicenter, Single-Blinded, Randomized Study. Phase 4
Not yet recruiting NCT04774939 - EVLA and Optimal Timing of Sclerotherapy N/A
Not yet recruiting NCT04339088 - High Intensity Focused Ultrasound in PAtients With Varicose Veins in Singapore
Completed NCT04006184 - Retrospective Review of Saphenous Vein Incompetence: Venaseal Versus Endovenous Thermal Ablation
Not yet recruiting NCT01909024 - Pelvic Embolisation to Reduce Recurrent Varicose Veins - Recurrent N/A
Recruiting NCT03250247 - Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial) N/A
Active, not recruiting NCT05707169 - Comparison of Zero- and Two-centimeter Distance From Sapheno-femoral Junction in Laser Ablation of Varicose Vein N/A
Active, not recruiting NCT03820947 - VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial N/A
Recruiting NCT04384315 - Efficacy and Safety of Endovenous Radio Frequency (EVRF) for Treatment of Varicose Veins in Singapore
Completed NCT01549860 - Effects of Non Contact Low Frequency Ultrasound in Healing Venous Leg Ulcers N/A
Completed NCT00842296 - ClosureFAST - Radiofrequency Great Saphenous Vein Treatment N/A
Completed NCT03893201 - A Singapore Venaseal Real World Post-Market Evaluation Study